242 related articles for article (PubMed ID: 18979105)
1. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients.
Kumor A; Daniel P; Pietruczuk M; Małecka-Panas E
Int J Colorectal Dis; 2009 Mar; 24(3):275-81. PubMed ID: 18979105
[TBL] [Abstract][Full Text] [Related]
2. The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas.
Demir N; Ahıshalı E; Dolapçıoğlu C; Ercan Ş; Orçun Kaptanağası A; Dabak R; Yücel N; Sargın M; Uygur Bayramiçli O
Turk J Gastroenterol; 2015 Jan; 26(1):20-4. PubMed ID: 25698266
[TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes.
Deng L; Zhao X; Chen M; Ji H; Zhang Q; Chen R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):63. PubMed ID: 32393372
[TBL] [Abstract][Full Text] [Related]
4. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.
Nakajima TE; Yamada Y; Hamano T; Furuta K; Matsuda T; Fujita S; Kato K; Hamaguchi T; Shimada Y
Cancer Sci; 2010 May; 101(5):1286-91. PubMed ID: 20331631
[TBL] [Abstract][Full Text] [Related]
5. Alteration of Leptin and Adiponectin in Multistep Colorectal Tumorigenesis.
Name N; Boonpipattanapong T; Palanusont A; Maneechay W; Sangkhathat S
Asian Pac J Cancer Prev; 2016; 17(4):Page. PubMed ID: 27221946
[TBL] [Abstract][Full Text] [Related]
6. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.
Daniel P; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska O; Malecka-Panas E
Int J Colorectal Dis; 2007 Oct; 22(10):1165-72. PubMed ID: 17394006
[TBL] [Abstract][Full Text] [Related]
8. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
9. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of leptin, adiponectin and resistin in relation to clinical characteristics in normal pregnancy and preeclampsia.
Song Y; Gao J; Qu Y; Wang S; Wang X; Liu J
Clin Chim Acta; 2016 Jul; 458():133-7. PubMed ID: 27154800
[TBL] [Abstract][Full Text] [Related]
11. Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD.
Mokrowiecka A; Daniel P; Jasinska A; Pietruczuk M; Pawlowski M; Szczesniak P; Orszulak-Michalak D; Malecka-Panas E
Hepatogastroenterology; 2012; 59(120):2395-9. PubMed ID: 22944288
[TBL] [Abstract][Full Text] [Related]
12. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC).
Karapanagiotou EM; Tsochatzis EA; Dilana KD; Tourkantonis I; Gratsias I; Syrigos KN
Lung Cancer; 2008 Sep; 61(3):391-7. PubMed ID: 18342391
[TBL] [Abstract][Full Text] [Related]
13. Interaction between adiponectin and leptin influences the risk of colorectal adenoma.
Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
Cancer Res; 2010 Jul; 70(13):5430-7. PubMed ID: 20516125
[TBL] [Abstract][Full Text] [Related]
14. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
15. Association between adiponectin, resistin, insulin resistance, and colorectal tumors.
Gonullu G; Kahraman H; Bedir A; Bektas A; Yücel I
Int J Colorectal Dis; 2010 Feb; 25(2):205-12. PubMed ID: 19888587
[TBL] [Abstract][Full Text] [Related]
16. Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Cantarini L; Obici L; Simonini G; Cimaz R; Bacarelli MR; Merlini G; Vitale A; Lucherini OM; Brizi MG; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S108-14. PubMed ID: 22935190
[TBL] [Abstract][Full Text] [Related]
17. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.
Cantarini L; Brucato A; Simonini G; Imazio M; Cumetti D; Cimaz R; Bacarelli MR; Muscari I; Vitale A; Lucherini OM; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2013; 31(2):207-12. PubMed ID: 23137677
[TBL] [Abstract][Full Text] [Related]
18. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease.
Atwa M; Emara A; Balata M; Youssef N; Bayoumy N; Sherif A; Fiala L
Int J Dermatol; 2014 Oct; 53(10):e410-20. PubMed ID: 24168156
[TBL] [Abstract][Full Text] [Related]
20. Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis.
Joshi RK; Kim WJ; Lee SA
World J Gastroenterol; 2014 Jun; 20(24):7941-9. PubMed ID: 24976730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
